Head to Head Analysis: Oxbridge Re (NASDAQ:OXBR) and Ryan Specialty (NYSE:RYAN)

Ryan Specialty (NYSE:RYANGet Free Report) and Oxbridge Re (NASDAQ:OXBRGet Free Report) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation.

Profitability

This table compares Ryan Specialty and Oxbridge Re’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ryan Specialty 7.61% 47.93% 5.47%
Oxbridge Re -109.74% -48.04% -29.65%

Insider and Institutional Ownership

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are held by institutional investors. 52.2% of Ryan Specialty shares are held by insiders. Comparatively, 16.5% of Oxbridge Re shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Ryan Specialty has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Oxbridge Re has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Earnings & Valuation

This table compares Ryan Specialty and Oxbridge Re”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ryan Specialty $2.52 billion 6.07 $94.67 million $0.46 125.99
Oxbridge Re $550,000.00 18.34 -$2.73 million ($0.41) -3.22

Ryan Specialty has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Ryan Specialty and Oxbridge Re, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty 1 3 9 1 2.71
Oxbridge Re 1 0 1 0 2.00

Ryan Specialty presently has a consensus target price of $68.54, indicating a potential upside of 18.26%. Oxbridge Re has a consensus target price of $5.00, indicating a potential upside of 278.79%. Given Oxbridge Re’s higher possible upside, analysts clearly believe Oxbridge Re is more favorable than Ryan Specialty.

Summary

Ryan Specialty beats Oxbridge Re on 12 of the 15 factors compared between the two stocks.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.

About Oxbridge Re

(Get Free Report)

Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology. In addition, the company offers fractional aircraft ownership, jet card, aircraft brokerage, and charter service through its fleet of private aircraft. It distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.